Mitochondrial diabetes: molecular mechanisms and clinical presentation - PubMed (original) (raw)
Review
Mitochondrial diabetes: molecular mechanisms and clinical presentation
J Antonie Maassen et al. Diabetes. 2004 Feb.
Abstract
Mutations in mitochondrial DNA (mtDNA) associate with various disease states. A few mtDNA mutations strongly associate with diabetes, with the most common mutation being the A3243G mutation in the mitochondrial DNA-encoded tRNA(Leu,UUR) gene. This article describes clinical characteristics of mitochondrial diabetes and its molecular diagnosis. Furthermore, it outlines recent developments in the pathophysiological and molecular mechanisms leading to a diabetic state. A gradual development of pancreatic beta-cell dysfunction upon aging, rather than insulin resistance, is the main mechanism in developing glucose intolerance. Carriers of the A3243G mutation show during a hyperglycemic clamp at 10 mmol/l glucose a marked reduction in first- and second-phase insulin secretion compared with noncarriers. The molecular mechanism by which the A3243G mutation affects insulin secretion may involve an attenuation of cytosolic ADP/ATP levels leading to a resetting of the glucose sensor in the pancreatic beta-cell, such as in maturity-onset diabetes of the young (MODY)-2 patients with mutations in glucokinase. Unlike in MODY2, which is a nonprogressive form of diabetes, mitochondrial diabetes does show a pronounced age-dependent deterioration of pancreatic function indicating involvement of additional processes. Furthermore, one would expect that all mtDNA mutations that affect ATP synthesis lead to diabetes. This is in contrast to clinical observations. The origin of the age-dependent deterioration of pancreatic function in carriers of the A3243G mutation and the contribution of ATP and other mitochondrion-derived factors such as reactive oxygen species to the development of diabetes is discussed.
Similar articles
- Molecular mechanisms of mitochondrial diabetes (MIDD).
Maassen JA, Janssen GM, 't Hart LM. Maassen JA, et al. Ann Med. 2005;37(3):213-21. doi: 10.1080/07853890510007188. Ann Med. 2005. PMID: 16019720 Review. - Molecular and clinical aspects of mitochondrial diabetes mellitus.
Maassen JA, van Essen E, van den Ouweland JM, Lemkes HH. Maassen JA, et al. Exp Clin Endocrinol Diabetes. 2001;109(3):127-34. doi: 10.1055/s-2001-14834. Exp Clin Endocrinol Diabetes. 2001. PMID: 11409293 Review. - Mitochondrial gene mutations in the tRNA(Leu(UUR)) region and diabetes: prevalence and clinical phenotypes in Japan.
Ohkubo K, Yamano A, Nagashima M, Mori Y, Anzai K, Akehi Y, Nomiyama R, Asano T, Urae A, Ono J. Ohkubo K, et al. Clin Chem. 2001 Sep;47(9):1641-8. Clin Chem. 2001. PMID: 11514398 - Diabetes mellitus associated with the 3243 mitochondrial tRNA(Leu)(UUR) mutation: insulin secretion and sensitivity.
Suzuki Y, Iizuka T, Kobayashi T, Nishikawa T, Atsumi Y, Kadowaki T, Oka Y, Kadowaki H, Taniyama M, Hosokawa K, Asahina T, Matsuoka K. Suzuki Y, et al. Metabolism. 1997 Sep;46(9):1019-23. doi: 10.1016/s0026-0495(97)90272-9. Metabolism. 1997. PMID: 9284890 - Clinical manifestations due to a point mutation of the mitochondrial tRNAleu(UUR) gene in five families with diabetes mellitus.
Shigemoto M, Yoshimasa Y, Yamamoto Y, Hayashi T, Suga J, Inoue G, Okamoto M, Jingami H, Tsuda K, Yamamoto T, Yagura T, Oishi M, Tsujii S, Kuzuya H, Nakao K. Shigemoto M, et al. Intern Med. 1998 Mar;37(3):265-72. doi: 10.2169/internalmedicine.37.265. Intern Med. 1998. PMID: 9617861
Cited by
- Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.
Aroor AR, Mandavia C, Ren J, Sowers JR, Pulakat L. Aroor AR, et al. Cardiorenal Med. 2012 May;2(2):87-109. doi: 10.1159/000335675. Epub 2012 Feb 7. Cardiorenal Med. 2012. PMID: 22619657 Free PMC article. - Physiological insights gained from gene expression analysis in obesity and diabetes.
Keller MP, Attie AD. Keller MP, et al. Annu Rev Nutr. 2010 Aug 21;30:341-64. doi: 10.1146/annurev.nutr.012809.104747. Annu Rev Nutr. 2010. PMID: 20415584 Free PMC article. Review. - Prevalence and progression of diabetes in mitochondrial disease.
Whittaker RG, Schaefer AM, McFarland R, Taylor RW, Walker M, Turnbull DM. Whittaker RG, et al. Diabetologia. 2007 Oct;50(10):2085-9. doi: 10.1007/s00125-007-0779-9. Epub 2007 Jul 26. Diabetologia. 2007. PMID: 17653689 - Mitochondria Related Cell Death Modalities and Disease.
Tian C, Liu Y, Li Z, Zhu P, Zhao M. Tian C, et al. Front Cell Dev Biol. 2022 Mar 7;10:832356. doi: 10.3389/fcell.2022.832356. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35321239 Free PMC article. Review. - Cardiovascular Manifestations of Mitochondrial Disease.
Duran J, Martinez A, Adler E. Duran J, et al. Biology (Basel). 2019 May 11;8(2):34. doi: 10.3390/biology8020034. Biology (Basel). 2019. PMID: 31083569 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical